Cuban Lung Cancer Vaccine CIMAVax-EGF Approved in Belarus: A Milestone in Cancer Treatment
In a significant development for global cancer treatment, Belarus has officially approved the use of CIMAVax-EGF, a pioneering lung cancer vaccine developed by Cuba’s Center for Molecular Immunology (CIM). This approval marks a crucial step in expanding the reach of this innovative therapy, showcasing Cuba’s continued prominence in biotechnology and pharmaceutical research despite ongoing challenges….